Current SATVI news
Associate Professor Tom Scriba has co-authored a research paper titled: "Integrating Non-human Primate, Human, and Mathematical Studies to Determine the Influence of BCG Timing on H56 Vaccine Outcomes" appearing in the Frontiers journal.
SATVI Authors dr Elisa Nemes, Professor Mark Hatherill and Associate Professor Tom Scriba have published a paper titled: "Prospects for a vaccine to prevent HIV related Tuberculosis" appearing in the Current opinions in HIV/AIDS journal.
For this year’s Mandela Day the South African Tuberculosis Vaccine Initiative (SATVI) has announced its support for community based soup kitchens in the Cape Winelands District.
Scientists from the South African Tuberculosis Vaccine Initiative (SATVI) and the Desmond Tutu HIV Foundation have announced publication in the New England Journal of Medicine of the results of an innovative clinical trial that provides encouraging new evidence that TB vaccines could prevent sustained TB infections in high-risk adolescents. our latest TB vaccine clinical trial have been published in the New England Journal of Medicine.
On Friday 22 June 2018 the Worcester SATVI field site hosted UCT Honours Vaccinology students.
SATVI's Associate Professor Tom Scriba has co-authored a research paper titled "Latest research: A Serum Circulating miRNA Signature for Short-Term Risk of Progression to Active Tuberculosis Among Household Contacts" appearing in the Frontiers in Immunology.
The 2017 SATVI Annual Report is now available.
Researchers at the South African Tuberculosis Vaccine Initiative have co-authored an article titled "Four-gene Pan-African Blood Signature Predicts Progression to Tuberculosis" appearing in the American Journal of Respiratory and Critical Care Medicine.
The South African Tuberculosis Vaccine Initiative invites applications for a Postdoctoral Fellowship to conduct research on the Immunology of TB vaccines. NOW CLOSED.
SATVI researchers have published an article titled: "Safety and immunogenicity of the novel tuberculosis vaccine ID93 + GLA-SE in BCG-vaccinated healthy adults in South Africa: a randomised, double-blind, placebo-controlled phase 1 trial" appearing in the latest Lancet Respiratory Medicine.
On the eve of World TB Day we launched the "TB under the Spotlight Science Engagement" initiative in Worcester in partnership with the Division of Molecular Biology and Human Genetics at the University Stellenbosch and the Department of Education on Tuesday 20 March 2018.
Read the latest news about the fight against TB in the Cape Winelands.